Polymorphisms in Ghrelin and Neuropeptide Y Genes Are Associated with Non-Hodgkin Lymphoma
暂无分享,去创建一个
A. Hubbard | E. Holly | P. Bracci | Martyn T. Smith | Luz Agana | D. Skibola | Shawn Chi | D. R. Skibola | Danica R. Skibola
[1] Peter Kraft,et al. Accounting for haplotype uncertainty in matched association studies: A comparison of simple and flexible techniques , 2005, Genetic epidemiology.
[2] D. Taub,et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. , 2004, The Journal of clinical investigation.
[3] M. Forrest,et al. Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[4] J. Konturek,et al. Brain-gut axis and its role in the control of food intake. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[5] S. Wen,et al. Association of obesity and cancer risk in Canada. , 2004, American journal of epidemiology.
[6] B. Ding. Distribution of the NPY 1128C allele frequency in different populations , 2003, Journal of Neural Transmission.
[7] Y. Kesäniemi,et al. Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus , 2003, Journal of internal medicine.
[8] E. Holly,et al. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. , 2003, American journal of epidemiology.
[9] M. Koulu,et al. Changes in diurnal sympathoadrenal balance and pituitary hormone secretion in subjects with Leu7Pro polymorphism in the prepro-neuropeptide Y. , 2003, The Journal of clinical endocrinology and metabolism.
[10] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[11] J. Coebergh,et al. Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma. , 2003, American journal of epidemiology.
[12] Lijun Li,et al. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? , 2003, Canadian journal of physiology and pharmacology.
[13] T. Yamamura,et al. Relevance of Neuropeptide Y for the neuroimmune crosstalk , 2003, Journal of Neuroimmunology.
[14] Pak Chung Sham,et al. GENECOUNTING: haplotype analysis with missing genotypes , 2002, Bioinform..
[15] J. Cerhan,et al. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. , 2002, American journal of epidemiology.
[16] E. Ravussin,et al. Role of ghrelin polymorphisms in obesity based on three different studies. , 2002, Obesity research.
[17] E. Holly,et al. Comparison of interviewed and non-interviewed non-Hodgkin's lymphoma (NHL) patients in the San Francisco Bay Area. , 2002, Annals of epidemiology.
[18] J. Hebebrand,et al. Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. , 2002, The Journal of clinical endocrinology and metabolism.
[19] R. Mcmurray,et al. Estrogen, prolactin, and autoimmunity: actions and interactions. , 2001, International immunopharmacology.
[20] E. Ravussin,et al. Circulating ghrelin levels are decreased in human obesity. , 2001, Diabetes.
[21] M. Boemi,et al. Influence of body mass on glycemic control in a type 2 diabetic population: a 3-year follow-up. , 2000, Archives of gerontology and geriatrics.
[22] E. Holly,et al. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. , 1999, American journal of epidemiology.
[23] M. van de Rijn,et al. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. , 1999, The Journal of rheumatology.
[24] E. Holly,et al. Hair-color products and risk for non-Hodgkin's lymphoma: a population-based study in the San Francisco bay area. , 1998, American journal of public health.
[25] F. Minuto,et al. Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture. , 1998, Fertility and sterility.
[26] Satoshi Obana,et al. Differential Effects of Neuropeptides on Cytokine Production by Mouse Helper T Cell Subsets , 1998, Neuroimmunomodulation.
[27] E. Holly,et al. Non-Hodgkin's lymphoma in homosexual men in the San Francisco Bay Area: occupational, chemical, and environmental exposures. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[28] E. Holly,et al. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: allergies, prior medication use, and sexual practices. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[29] D. Thomas,et al. Comparison of control subjects recruited by random digit dialing and area survey. , 1994, American journal of epidemiology.
[30] P. Villiger,et al. Neuropeptide Y is an inducible gene in the human immune system , 1994, Journal of Neuroimmunology.
[31] S. Schwartz,et al. Effect of Neuropeptide Y on Natural Killer Activity of Normal Human Lymphocytes , 1993, Brain, Behavior, and Immunity.
[32] J. Kelsey,et al. Evaluation of random digit dialing as a method of control selection in case-control studies. , 1992, American journal of epidemiology.
[33] I. Grant,et al. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] D. Moller,et al. Metabolic syndrome: a clinical and molecular perspective. , 2005, Annual review of medicine.
[35] Nathaniel Rothman,et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.
[36] R. Kuczmarski,et al. Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2001, Journal of the American Dietetic Association.
[37] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .